Managers / Q2 2023 · view latest →
Michelson Medical Research Foundation, Inc.
CIK 0001965304 · 11755 WILSHIRE BLVD., SUITE 1400, LOS ANGELES, CA, 90025 · (310) 806-9700
Summary
Michelson Medical Research Foundation, Inc. reported $141M in U.S.-listed holdings across 20 positions for Q2 2023.
The portfolio is heavily concentrated: SGOV alone accounts for 44.8% of reported value.
Compared with Q1 2023, the fund opened 1 new position and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 81.4% · $114M
- REIT · 13.6% · $19M
- Common Stock · 4.4% · $6M
- Closed-End Fund · 0.6% · $797,199
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SGOVISHARES TR | NEW | +119.6K | 119.6K | +$12M | $12M |
| RICE ACQUISITION CORP II | SOLD OUT | −51.0K | 0 | −$522,292 | $0 |
| ORION BIOTECH OPPORTUNTES CO | SOLD OUT | −50.8K | 0 | −$519,479 | $0 |
| AVBAVALONBAY CMNTYS INC | HELD | +0 | 44.5K | +$943,527 | $8M |
| IVVISHARES TR | HELD | +0 | 18.0K | +$622,959 | $8M |
| IVEISHARES TR | HELD | +0 | 51.9K | +$489,464 | $8M |
| AREALEXANDRIA REAL ESTATE EQ IN | HELD | +0 | 37.2K | −$450,483 | $4M |
| CRCCALIFORNIA RES CORP | HELD | +0 | 58.5K | +$396,876 | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SGOVISHARES TR | IBOXX HI YD ETF · 0-3 MNTH TREASRY · S&P 500 VAL ETF · CORE S&P500 ETF · CORE HIGH DV ETF · ISHARES BIOTECH · PFD AND INCM SEC | 44.82% | $63M | 643.2K |
| 2 | VEAVANGUARD TAX-MANAGED FDShistory → | VAN FTSE DEV MKT | 10.05% | $14M | 305.9K |
| 3 | BKLNINVESCO EXCH TRADED FD TR IIhistory → | SR LN ETF | 8.99% | $13M | 600.6K |
| 4 | BSVVANGUARD BD INDEX FDShistory → | SHORT TRM BOND | 8.86% | $12M | 164.8K |
| 5 | VWOVANGUARD INTL EQUITY INDEX Fhistory → | FTSE EMR MKT ETF | 6.85% | $10M | 236.6K |
| 6 | AVBAVALONBAY CMNTYS INChistory → | COM | 5.99% | $8M | 44.5K |
| 7 | PLDPROLOGIS INC.history → | COM | 3.70% | $5M | 42.4K |
| 8 | AREALEXANDRIA REAL ESTATE EQ INhistory → | COM | 3.01% | $4M | 37.2K |
| 9 | CRCCALIFORNIA RES CORPhistory → | COM STOCK | 1.88% | $3M | 58.5K |
| 10 | XBISPDR SER TRhistory → | S&P BIOTECH | 1.85% | $3M | 31.3K |
| 11 | TALOTALOS ENERGY INChistory → | COM | 1.38% | $2M | 139.8K |
| 12 | CRGYCRESCENT ENERGY COMPANYhistory → | CL A COM | 1.16% | $2M | 156.2K |
| 13 | BXPBOSTON PROPERTIES INC | COM | 0.89% | $1M | 21.7K |
| 14 | NMLNEUBERGER BERMAN ENERGY INFR | COM | 0.57% | $797,199 | 115.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $99M | 21 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $100M | 20 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $115M | 20 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $104M | 20 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $120M | 25 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $119M | 28 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $142M | 28 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $116M | 25 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $165M | 28 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $152M | 28 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $148M | 27 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $141M | 20 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $128M | 21 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $154M | 31 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.